CIK: 0001969764 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value ($000): $86,073 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PAGP | PLAINS GP HOLDINGS LP-CL | 1,272,360 | $27,178 | 31.6% | $18.82 | — | COMM | 72651A207 |
| MDGL | MADRIGAL PHARMACEUTICALS | 30,032 | $9,947 | 11.6% | $193.31 | +70.0% | COMM | 558868105 |
| — | AKERO THERAPEUTICS INC | 228,884 | $9,265 | 10.8% | $24.86 | — | COMM | 00973Y108 |
| PHAT | PHATHOM PHARMACEUTICALS I | 1,134,927 | $7,116 | 8.3% | $8.64 | -29.8% | COMM | 71722W107 |
| ACHV | ACHIEVE LIFE SCIENCES INC | 2,453,092 | $6,550 | 7.6% | $4.44 | -29.9% | COMM | 004468500 |
| — | APPLIED THERAPEUTICS INC | 11,285,420 | $5,517 | 6.4% | $2.53 | — | COMM | 03828A101 |
| RNAM | AVIDITY BIOSCIENCES INC | 178,500 | $5,269 | 6.1% | $6.68 | +365.9% | COMM | 05370A108 |
| ABEO | ABEONA THERAPEUTICS INC | 624,022 | $2,970 | 3.5% | $5.10 | +6.6% | COMM | 00289Y206 |
| TCRX | TSCAN THERAPEUTICS INC | 2,087,139 | $2,880 | 3.3% | $4.58 | -52.8% | COMM | 89854M101 |
| DCTH | DELCATH SYSTEMS INC | 177,600 | $2,261 | 2.6% | $13.84 | +2.5% | COMM | 24661P807 |
| SNDX | SYNDAX PHARMACEUTICALS IN | 183,259 | $2,251 | 2.6% | $20.44 | -31.0% | COMM | 87164F105 |
| ZVRA | ZEVRA THERAPEUTICS INC | 179,874 | $1,347 | 1.6% | $6.78 | +17.2% | COMM | 488445206 |
| MIST | MILESTONE PHARMACEUTICALS | 1,451,557 | $1,161 | 1.3% | $1.99 | 0.0% | COMM | 59935V107 |
| MATPF | MAAT PHARMA SACA | 166,423 | $1,038 | 1.2% | $6.26 | — | COMM | F5888J116 |
| CMPX | COMPASS THERAPEUTICS INC | 228,317 | $434 | 0.5% | $2.66 | 0.0% | COMM | 20454B104 |
| — | ATHIRA PHARMA INC | 1,492,792 | $425 | 0.5% | $2.43 | — | COMM | 04746L104 |
| — | EIGER BIOPHARMACEUTICALS | 146,381 | $423 | 0.5% | $5.00 | — | COMM | 28249U204 |
| — | CHINOOK THERAPEUTICS | 79,357 | $39 | 0.0% | — | — | COMM | 169CVR016 |